Uloric lawsuits are claiming that manufacturer Takeda Pharmaceuticals failed to notify users about the increased risk of cardiovascular death when taking the drug. The lawsuits were prompted by a revelation in 2018 that the gout drug had caused more heart-related deaths than a common competitor, allopurinol.Need a free Uloric case review? Talk with a lawyer right now
Why People Are Filing Uloric Lawsuits
Uloric lawsuits against Takeda Pharmaceuticals are focused primarily on the increased risk of death associated with the gout medication. Some lawsuits are also being filed by patients who claim they suffered other cardiovascular problems after taking Uloric, including stroke, pulmonary embolism (PE) and deep-vein thrombosis (DVT).
The claims of Uloric lawsuits center around the drug manufacturer’s responsibility to warn patients about potential side effects caused by its medications. Despite showing potential for increased risk of cardiovascular events in early clinical trials, however, Takeda did not adequately warn patients about those risks, according to plaintiffs. In November 2017, the U.S. Food and Drug Administration (FDA) ordered the drug company to further study the heart-related risks of Uloric, but family members of patients who died believe the company should have been more up front about the problems its prescription medication could cause.
Uloric and Heart Attacks
Uloric (febuxostat) is a medication used for treating gout, a painful type of arthritis caused by the buildup of uric acid, which in turn leads to aching, swelling, redness and other problems. Uloric works by reducing uric acid levels in the blood, thus reducing inflammation and alleviating symptoms.
Unfortunately, Uloric also has a potentially deadly side effect, an increased risk of heart-related deaths in patients with cardiovascular disease. According to the results of a clinical trial known as the CARES study, patients who took Uloric had a higher incidence of fatal myocardial infarctions (heart attacks leading to death) than patients who took allopurinol, another gout medicine.
The FDA issued a drug safety communication in November 2017, and results of the CARES study were published in March 2018 in The New England Journal of Medicine. However, the FDA did not require Takeda Pharmaceuticals to add a black box warning about this dangerous side effect until February 2019. At that time, the FDA also limited using Uloric to patients who are allergic to allopurinol or who have not had their gout treated effectively with that drug.Have you suffered a heart attack after taking Uloric? Get a free consultation today
Uloric Whistleblower Lawsuit
Before the current Uloric lawsuits, a whistleblower lawsuit was filed in 2010 by a former safety consultant for Takeda, Dr. Helen Ge. In her lawsuit, Dr. Ge alleged that Takeda purposely hid information about some very serious side effects of Uloric. She also claimed that Takeda covered up negative interactions with two drugs that treat gastrointestinal reflux disease (GERD), Kapidex/Dexilant and Prevacid.
Dr. Ge’s whistleblower lawsuit claims that Takeda knew about severe Uloric side effects from preapproval data – including kidney failure, congestive heart failure and liver failure – but the company failed to warn consumers appropriately by revising the drug label. As a result, patients and the government (through healthcare programs like Medicaid) paid significantly more money for Uloric prescriptions when they could have instead bought the much cheaper generic drug allopurinol, according to the lawsuit.
Takeda was ultimately able to get Dr. Ge’s whistleblower claims dismissed by the U.S. District Court for the District of Massachusetts. Dr. Ge appealed, but the appeals court upheld the dismissal on technical grounds, and the Supreme Court later refused to hear the case.
Current Uloric Litigation
Because Uloric lawsuits are still so new, there is very little information available. As more information about current lawsuits becomes available, we will provide details here.
If you or a loved one took Uloric and experienced a heart attack, stroke, angina or another cardiovascular side effect, talk to a lawyer right away to get a free case evaluation.
Uloric Settlements and Verdicts
No settlements or verdicts in Uloric cases have been finalized at this time.
Uloric Lawsuit FAQs
Am I Eligible to File a Uloric Lawsuit?
Patients (or their surviving family members) who took Uloric may be able to file a lawsuit against the company if they suffered from a cardiovascular event after taking the gout drug. This includes:
- Heart attack
- Blood clots
- Angina (chest pain)
To find out if your case is viable, you can sign up for a free consultation with an experienced prescription drug lawyer.
What Compensation Is Available for Uloric Lawsuits?
Each individual case is going to differ in the allowable compensation. In general, however, plaintiffs may be able to receive damages for the following:
- Medical costs related to treatment of severe side effects
- Lost income due to disability or untimely death
- Loss of companionship or consortium
- Funeral expenses for wrongful death
During your free review, your lawyer will go over any other compensation you may be eligible to receive based on the facts of your case.
How Much Does a Uloric Lawyer Cost?
Uloric lawsuits are being filed on a contingency basis, meaning that your lawyers will only be paid if they help you receive money as part of your legal claim. When talking with your lawyer, you should be sure to ask any questions you have about fees and other costs related to your lawsuit.Free Uloric Case Review
Find a Lawyer Now